Target Price | $180.69 |
Price | $170.63 |
Potential |
5.89%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target Quest Diagnostics 2026 .
The average Quest Diagnostics target price is $180.69.
This is
5.89%
register free of charge
$195.00
14.28%
register free of charge
$160.00
6.23%
register free of charge
|
|
A rating was issued by 22 analysts: 10 Analysts recommend Quest Diagnostics to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2026 of
5.89%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 9.87 | 10.78 |
6.70% | 9.23% | |
EBITDA Margin | 19.33% | 19.97% |
0.10% | 3.32% | |
Net Margin | 8.61% | 8.79% |
4.54% | 2.06% |
16 Analysts have issued a sales forecast Quest Diagnostics 2025 . The average Quest Diagnostics sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Quest Diagnostics EBITDA forecast 2025. The average Quest Diagnostics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Quest Diagnostics Analysts have issued a net profit forecast 2025. The average Quest Diagnostics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 7.66 | 8.54 |
1.86% | 11.49% | |
P/E | 19.98 | |
EV/Sales | 2.37 |
9 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics EPS is
This results in the following potential growth metrics and future valuations:
Quest Diagnostics...
Analyst | Rating | Action | Date |
---|---|---|---|
Redburn Atlantic |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
Baird |
Locked
➜
Locked
|
Locked | Mar 20 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | Feb 04 2025 |
UBS |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 03 2025 |
Analyst Rating | Date |
---|---|
Locked
Redburn Atlantic:
Locked
➜
Locked
|
Apr 02 2025 |
Locked
Baird:
Locked
➜
Locked
|
Mar 20 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
Mar 04 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 04 2025 |
Locked
UBS:
Locked
➜
Locked
|
Feb 03 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Feb 03 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.